Both are injectable medications originally developed for type 2 diabetes that also produce significant weight loss
A consultation, where you can discuss your full medical history and any concerns, will help determine if it's a fit for you
Patients appreciate that progress feels steady and realistic
Arnold, MD, FACHE, FASA shares new multi-society clinical practice guidance on GLP-1 drugs before surgery
Steed H, Walsh S, Reynolds N
However, our study focuses specifically on pharmacological aspects of GLP-1R agonism, with prolonged incubations deliberately chosen to mimic in vivo drug exposure, and knockdown of both -arrestin isoforms to better approximate the response to exendin-phe1 and related agonists